Keywords: teijin, launches, alendronate, japan, started, selling, osteoporosis
Teijin launches alendronate in Japan
Article | 03 September 2001
Teijin has started selling the osteoporosis drug alendronate, originallydeveloped by Merck & Co, in Japan, after its price-listing by the Ministry ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
